Ibriturnomab tiuxetan (Zevalin) in the conditioning regimen for autologous and reduced-intensity allogeneic stem-cell transplantation in patients with chemo-refractory non-Hodgkin's lymphoma.

被引：0
作者：
Shimoni, A [1 ]
Zwas, T [1 ]
Oksman, Y [1 ]
Hardan, I [1 ]
Shem-Tov, N [1 ]
Yerushalmi, R [1 ]
Avigdor, A [1 ]
Ben-Bassat, I [1 ]
Nagler, A [1 ]
机构：
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1131
引用
收藏
页码：329A / 329A
页数：1
相关论文
共 50 条
[41]   Reduced-intensity allogeneic transplantation following autologous transplantation is feasible in patients with high-risk non-Hodgkin lymphoma [J].
Crocchiolo, R. ;
Castagna, L. ;
Furst, S. ;
El-Cheikh, J. ;
Faucher, C. ;
Oudin, C. ;
Devillier, R. ;
Bouabdallah, R. ;
Coso, D. ;
Broussais, F. ;
Ivanov, V. ;
Schiano, J. ;
Aurran, T. ;
Chabannon, C. ;
Balzarotti, M. ;
Santoro, A. ;
Blaise, D. .
BONE MARROW TRANSPLANTATION, 2012, 47 :S439-S440
[42]   Phase II study of radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen for allogeneic haematopoietic cell transplantation in patients with advanced indolent non-Hodgkin lymphoma [J].
Bethge, W. A. ;
Lange, T. ;
von Harsdorf, S. ;
Bornhaeuser, M. ;
Federmann, B. ;
Stadler, M. ;
Uharek, L. ;
Stelljes, M. ;
Knop, S. ;
Wulf, G. ;
Dittmann, H. ;
Faul, C. ;
Vogel, W. ;
Kanz, L. ;
Bunjes, D. .
BONE MARROW TRANSPLANTATION, 2010, 45 :S44-S44
[43]   A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation [J].
Le Blanc, K ;
Remberger, M ;
Uzunel, M ;
Mansson, J ;
Barkholt, L ;
Ringdén, O .
TRANSPLANTATION, 2004, 78 (07) :1014-1020
[44]   Autologous hematopoietic cell transplantation (ASCT) for patients with chemo-refractory Hodgkin's lymphoma (HL). [J].
Fung, HC ;
Nademanee, A ;
Krishnan, A ;
Smith, D ;
Molina, A ;
Bhatia, S ;
Popplewell, L ;
Cohen, S ;
Zain, J ;
Schriber, J ;
Vora, N ;
Kogut, N ;
Falk, P ;
Forman, SJ .
BLOOD, 2003, 102 (11) :119A-119A
[45]   Comparison between BEAM and Yttrium-90 Ibritumomab Tiuxetan (Zevalin)-BEAM as conditioning regimen before autologous stem cell transplantation in patients with non-Hodgkin B-Cell Lymphoma [J].
Chic Acevedo, C. ;
Garcia Torres, E. ;
Llamas Poyato, M. J. ;
Rodriguez, G. ;
Martin, C. ;
Rojas, R. ;
Serrano, J. ;
Tabares, S. ;
Vallejo, J. A. ;
Sanchez, J. .
BONE MARROW TRANSPLANTATION, 2015, 50 :S224-S224
[46]   Outcome of allogeneic haematopoietic cell transplantation with antithymocyte globulin containing reduced-intensity conditioning in non-Hodgkin lymphoma. A single-centre experience [J].
Palomo, P. ;
Navarro, B. ;
Ruiz, E. ;
Fores, R. ;
Regidor, C. ;
Sanjuan, I. ;
Cabrera, R. ;
Fernandez, M. ;
Garcia-Marco, J. .
BONE MARROW TRANSPLANTATION, 2008, 41 :S208-S209
[47]   Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease [J].
Martin-Salces, M ;
de la Guía, AL ;
Hernández, D ;
Kerguelén, A ;
Cobo, T ;
Canales, M ;
G-Bustos, J ;
Hernández-Navarro, F .
BONE MARROW TRANSPLANTATION, 2006, 37 :S323-S323
[48]   Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma [J].
Morris, EC ;
Mackinnon, S .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (01) :129-142
[49]   Zevalin-beam conditioning therapy by autologous peripheral stem cell transplantation in follicular non-Hodgkin lymphoma patients [J].
Remenyi, Gy. ;
Kiss, A. ;
Batar, P. ;
Szasz, R. ;
Radvanyi, G. ;
Udvardy, M. .
BLOOD REVIEWS, 2007, 21 :S89-S89
[50]   Clinical and molecular disease eradication in patients with poor prognosis non-Hodgkin lymphoma by allogeneic haematopoietic stem cell transplantation with reduced-intensity or myeloablative conditioning [J].
Mitterbauer, M ;
Kalhs, P ;
Jaeger, U ;
Mannhalter, C ;
Rabitsch, W ;
Fischer, G ;
Dieckmann, K ;
Simonitsch-Klupp, I ;
Hoecker, P ;
Hinterberger, W ;
Rosenmayr, A ;
Mitterbauer, G ;
Greinix, HT .
BONE MARROW TRANSPLANTATION, 2005, 35 :S73-S73
12345